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ABSTRACT
Introduction: Lipodystrophy is related to the use of highly active antiretroviral therapy (HAART) 
and can cause aesthetic stigma and increase the risk of developing cardiovascular diseases. Physical 
activity may be a valid alternative for the treatment and prevention of lipodystrophy. However, 
few studies address this issue. The objective of this study was to assess lipodystrophy related to 
highly active antiretroviral therapy in HIV/AIDS patients with different physical activity habits. 
Methods: The sample was composed of 42 HIV/AIDS patients taking HAART medication who 
were visiting the Counseling and Testing Center (CTC) in Presidente Prudente. The level of 
physical activity was obtained using the International Physical Activity Questionnaire (IPAQ); 
lipodystrophy was diagnosed using a self-report questionnaire that was administered to the patient 
and then followed up by medical confirmation. The percentage of trunk fat was estimated by dual 
X-Ray absorptiometry (DEXA). Information about sex, age, length of HAART treatment, CD4+ 
T lymphocyte count (CD4) and viral load was also collected. Results: A higher prevalence of 
lipodystrophy was observed in the sedentary group when compared to the physically active group, 
which indicates that physical activity may be a protective factor in relation to the occurrence of 
lipodystrophy. The group that had a higher CD4 had a higher proportion of lipodystrophy and a 
higher proportion of younger and physically active individuals. The patients with lipodystrophy had 
a higher percentage of trunk fat and were more sedentary than active individuals. Conclusions: 
A physically active lifestyle has a protective effect against the occurrence of lipodystrophy related 
to HAART.
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RESUMO
Introdução: A lipodistrofia relacionada ao uso de terapia antirretroviral (TARV) pode causar 
estigma estético e elevar o risco de doenças cardiovasculares. A atividade física pode ser uma 
alternativa válida para o tratamento e prevenção da lipodistrofia. Entretanto, poucos estudos tratam 
dessa temática. O objetivo deste estudo foi verificar a ocorrência de lipodistrofia relacionada ao uso 
de TARV em portadores de HIV/AIDS, com diferentes hábitos de atividades físicas. Métodos: 
A casuística foi formada por 42 portadores de HIV em uso de TARV, do Centro de Testagem 
e Aconselhamento de Presidente Prudente. Para obtenção do nível de atividade física aplicou-
se o Questionário Internacional de Atividade Física (IPAQ); a lipodistrofia foi diagnosticada 
pelo autorrelato do paciente e a confirmação médica. O percentual de gordura de tronco foi 
estimado pela absortometria por raio-X de dupla energia (DEXA). Foram coletados também 
dados referentes a sexo, idade, tempo de uso de TARV, valores de CD4 e carga viral. Resultados: 
Verificou-se maior ocorrência de lipodistrofia no grupo sedentário quando comparado ao ativo, 
além de fator protetor da prática da atividade física em relação à ocorrência da lipodistrofia. O 
grupo com valores mais elevados de CD4 também apresentou maior proporção de sujeitos com 
lipodistrofia, além de maior proporção de ativos e de indivíduos com menor faixa etária. Os 
acometidos pela lipodistrofia apresentaram maiores valores de percentual de gordura de tronco, 
bem como, os sedentários em relação aos ativos. Conclusões: O estilo de vida fisicamente ativa 
resultou em efeito protetor para ocorrência da lipodistrofia relacionada ao uso da TARV.
Palavras-chaves: Composição corporal. Lipodistrofia. HIV/AIDS. Atividade física.
After 1996, with the introduction of highly 
active antiretroviral therapy (HAART), there was 
a significant increase in survival and improvement 
in the quality of life for HIV/AIDS patients1-3. 
With increased survival, the long-term effects of 
infection have become a focus of the scientific 
community. Therefore, we started to pay attention 
to the side effects of HAART. The focus of our 
research is lipodystrophy, which is characterized by 
the redistribution of body fat from the limbs, face, 
and buttocks (lipoatrophy) to the central region of 
the body (lipohypertrophy)4.
Besides creating a new aesthetic stigma5 for 
this population, these changes in the distribution 
of adipose tissue may also increase the risk of 
developing cardiovascular diseases and diabetes6-8 
due to the excessive accumulation of abdominal fat. 
Thus, it is important to increase our understanding 
of the health consequences of central obesity, also 
called lipodystrophy, in HIV/AIDS patients.
Considering that currently there is no cure for 
HIV infection and that HAART is essential for 
maintaining the survival of infected people, it is 
necessary to adopt strategies to prevent and treat 
lipodystrophy and other possible side effects.
Therefore, physical activity may be used as 
an alternative intervention. Physical therapy has 
been recommended by Mutimura et al9, Robinson 
et al10 Lindegaard et al11, Terry et al12 and Thoni 
et al13 who found that physical activity can help 
reduce central fat and the metabolic consequences 
that result from its accumulation. Physical therapy 
can induce favorable changes in both lipids and 
glucose levels and reduce the risk of developing 
cardiovascular disease. Despite evidence regarding 
the benefits of systematic physical exercise, physical 
activity also requires significant energy expenditure. 
Studies on the relationship of physical activity and 
central fat accumulation are scarce. Specifically, we 
were only able to find studies by Florindo et al.14, 
http://dx.doi.org/10.1590/S0037-86822011000400004 
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Ramirez-Marrero et al.15 and Domingo et al.16. The results of these 
studies suggest that there is an inverse relationship between high 
levels of physical activity and lower rates of central body fat; however, 
only one16 study addresses lipodystrophy.
The objective of the present study was to assess the prevalence of 
lipodystrophy associated with the use of highly active antiretroviral 
therapy in HIV/AIDS patients with different physical activity habits.
During a three months period, all patients that attended the 
Counseling and Testing Center (CTC) were invited to participate 
in this study. This time frame was chosen because, according to the 
clinical staff of the institution, patients are recommended to return at 
least every three months for monitoring of immunological markers.
The CTC had the medical records of 638 patients, of which 635 
were treated during the data collection period. The lead researcher 
was on location during the hours of the scheduled appointments for 
all three months. All patients were invited to participate; however, only 
101 (15.9%) agreed to participate and go to the UNESP Campus at 
Presidente Prudente. They received a card with the local date and time 
of their appointment, at which they filled out the physical activity 
questionnaire, provided a self-report of lipodystrophy and had their 
body composition estimated by Dual X-Ray Absorptiometry (DEXA). 
Only 55 patients participated in the data collection. The interviews 
and evaluations were performed in the Centro de Estudos e Laboratório 
de Avaliação e Prescrição de Atividades Motoras (CELAPAM) at the 
Universidade Estadual Paulista (UNESP), Campus de Presidente 
Prudente, State of São Paulo, Brazil. The lead investigator of the project, 
aided by two trained collaborators, performed all of the procedures.
The sample included HIV/AIDS patients of both sexes who 
were over 18 years of age and were being treated with HAART. 
Additionally, the participants were not prisoners, did not have 
pacemakers and were not pregnant.
Of the 55 patients who were evaluated, only 42 met the 
requirements for the study. Patients were excluded for the following 
reasons: under 18 years of age (n = 1); reported recent applications of 
a synthetic substance to shape the body (n = 1); did not complete the 
assessment because of malaise (n = 1); reported a false name at the time 
of data collection (these patients were precluded for ethical reasons 
and to prevent them from derailing efforts to collect information from 
their clinical record) (n = 1); and were not taking HAART (n = 9).
Patients were informed about the objectives of the study and 
the exams that would be performed. It was clearly explained that the 
data collected during the survey would be used strictly for scientific 
purposes and that the anonymity of the participants would be ensured.
Diagnosis of lipodystrophy 
Because there is no consensus on how best to diagnose 
lipodystrophy, we decided to use self-reporting with clinical 
confirmation by the physician responsible for monitoring the patients 
according to the procedures of Mutimura et al.9 and Thoni et al.13
Self-reports were collected through interviews. The lead 
researcher explained to the patient that lipodystrophy is related to 
antiretroviral therapy, explained to the  patient how it manifests in 
the body and then asked the patient if, after starting HAART, the 
patient had experienced a considerable accumulation of fat in the 
central region of the body.
Physical activity evaluation
The level of physical activity was determined by the International 
Physical Activity Questionnaire (IPAQ) - short version17. The 
information was obtained by interview. The classification proposed 
by Sjostrom et al.18 was used, and the subjects were classified as active 
(high and moderate level of physical activity) or sedentary (low level 
of physical activity)
Body composition assessment
Dual-energy X-ray absorptiometry (DEXA) (GE-LUNAR DPX-
NT) was used to estimate the percentage of trunk fat.
The evaluation was performed according to the manufacturer's 
recommendation. The subject was positioned in the supine position 
and stood still while the measurement was taken. The results were 
transmitted to a computer connected to the device and then stored 
in an Excel spreadsheet for further statistical analysis.
Biochemical markers related to the disease and
duration of HAART
The following data on additional variables were collected from 
clinical records of the patients in the CTC: CD4, viral load and the 
duration of HAART use. The date these tests not exceeded the three 
months of the other evaluations. The results from these tests are as 
follows: CD4 (cells/mm3): I) < 282, II) > 282, 282 was the mean value; 
viral load (copies/ml): I) < 50 = undetectable, II) > 50 detectable.
Statistical analyses
The Kolmogorov Smirnov test was used to analyze all continuous 
variables, and all the data were normally distributed.
To characterize the variables, we used descriptive statistics 
including the mean, standard deviation and distribution of absolute 
and relative frequencies.
The chi-square test was used to determine whether there was 
an association between the diagnosis of lipodystrophy and sex, 
age, physical activity level and duration of HAART. The same test 
was also used to analyze the association of CD4 and viral load with 
gender, age, physical activity level and lipodystrophy. The odds ratio 
test (OR) was used to determine the association between physical 
activity level and lipodystrophy.
The Student's t-test for independent samples was used to 
determine whether there were differences in the percentage of trunk 
fat in relation to lipodystrophy and physical activity level.
SPSS software, version 13.0 was used for the analyses. The 
adopted significance level was set to 5%.
Ethical considerations
The study was approved by the Ethics committee in Research 
at the Universidade Estadual Paulista Campus de Presidente Prudente 
(protocol number 35/2010) and followed the recommendations 
of the Declaration of Helsinki for human research. All participants 
signed a consent form.
Distribution of absolute and relative frequencies of the variables 
sex, age, activity level and lipodystrophy. Of the 42 patients, 54.8% 
were male. The age of the participants ranged from 31 to 59 years. 
A total of 45.2% of the individuals were in the sedentary group. 
Lipodystrophy was diagnosed in 42.9% of the studied cases (Table 1).
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TABLE 2 - Distribution of absolute and relative frequencies according to the 
presence or absence of lipodystrophy.
                                            Lipodystrophy
 yes AF (RF) no AF (RF)  
Variables n % n % χ2 p
Sex    
male 7 30.4 16 69.6 2.180 0.140
female 11 57.9 8 42.1  
Age (years)    
31-42 10 45.5 12 54.5 0.002 0.964
43-59 8 40.0 12 60.0  
Physical activity    
active 6 26.1 17 73.9 4.423 0.035
sedentary 12 63.2 7 36.8  
HAART use (years)    
< 8  5 23.8 16 76.2 4.764 0.029
> 8  13 61.9 8 38.1  
Chi-square statistical test (p < 0.05), AF: absolute frequency, RF: relative frequency 
(%), HAART: highly active antiretroviral therapy.
TABLE 1 - Distribution of absolute and relative frequencies of the variables 
sex, age, activity level and lipodystrophy.
     Frequency
Variables absolute relative (%)
Sex  
male 23 54.8
female 19 45.2
Age (years)  
31-42 22 52.4
43-59 20 47.6
Physical activity level  
active 23 54.8
sedentary 19 45.2
Lipodystrophy  
yes 18 42.9
no 24 57.1
TABLE 3 - Distribution of absolute and relative frequencies by the CD4 and viral load.
                                           CD4 (cells/mm3)               Viral load (copies/ml)
 <282 >282 <50 >50  
Variable AF (RF) AF (RF) χ2 p AF (RF) AF (RF) χ2 p
Sex        
male 15 (65.2)   8 (34.8) 3.460 0.063   9 (39.1) 14 (60.9) 3.717 0.054
female   6(31.6) 13 (68.4)   14 (73.7) 5 (26.3)  
Age (years)        
31-42 7 (31.8) 15 (68.2) 4.677 0.031 11 (50) 11 (50.0) 0.116 0.734
43-59 14 (70.0)   6 (30)   12 (60)   8 (40.0)  
PA level        
active   7 (30.4) 16 (69.6) 6.151 0.013 12 (52.2) 11 (47.8) 0.004 0.953
sedentary 14 (73.7)   5 (26.3)   11 (57.9)   8 (42.1)  
Lipodystrophy        
yes   5 (27.8) 13 (72.2) 4.764 0.029 11 (61.1)   7(38.9) 0.162 0.687
no 16 (66.7)   8 (33.3)   12 (50.0) 12 (50.0)  
PA: physical activity, AF: absolute frequency, RF: relative frequency (%).
The distribution of absolute and relative frequencies (%) 
of the studied variables according to the presence or absence of 
lipodystrophy and related statistical tests. There were no statistically 
significant differences in lipodystrophy when compared to sex 
(p = 0.140) and age (p = 0.964). However, the sedentary patients 
had a higher occurrence of the analyzed outcome when compared 
to the active patients (p = 0.035) or patients that had been taking 
HAART longer (p = 0.029) compared to patients who had been 
using the drugs for a smaller time period (Table 2).
The CD4 and viral loads and their relationship to the other 
variables that were measured. The CD4 and the viral load are 
significantly associated with age (p = 0.031), physical activity level 
(p = 0.013) and lipodystrophy (p = 0.029) (Table 3).
The binary logistic regression results indicate that there is an 
association between higher levels of physical activity and a lower 
incidence of lipodystrophy. In the multivariate model, active 
individuals had a 79% (OR = 0.21) less chance of developing 
lipodystrophy when compared with sedentary individuals (Table 4).
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The group with lipodystrophy had a statistically higher percentage 
of trunk fat than the group that did not have the syndrome as well as 
the sedentary group compared to the active group (Table 5).
TABLE 5 - Mean and standard deviation of the percentage of trunk fat of 
individuals with and without lipodystrophy according to physical activity levels.
    Percentage of trunk fat 
 mean SD p
Lipodystrophy   
yes 36.4 +8.2 0.005
no 26.6 +12.1 
Physical activity level   
active 26.8 + 12.9 0.013
sedentary 35.6 +7.4 
Note: statistical test: Student’s t-test for independent samples. SD: standard deviation.
TABLE 4 - Distribution of absolute and relative frequencies according to 
physical activity level and the respective logistic regression test.
 Lipodystrophy Binary logistic
 positive diagnosis regression 
Physical activity AF (RF%) OR CI95% P
Active 6 (26.1) 0.21 (0.06-0.77) 0.019
Sedentary 12 (63.2) 1.00 - -
CI: confidence interval of 95%: confidence interval of 95%; OR: odds ratio, 
AF: absolute frequency, RF: relative frequency (%).
DISCUSSION
In this study, lipodystrophy was observed in 42.9% of the 
cases. The prevalence of lipodystrophy in any of the three forms 
of manifestation (lipoatrophy, lipodystrophy or mixed) is not well 
established in the literature. The fact that there is no consensus on 
the diagnostic method and the differences in the studied populations 
may account for variation between studies19-22. In a review by Tien and 
Grunfeld23, several studies on lipodystrophy were analyzed, which 
reported that the rates of lipodystrophy range from 30% to 62%.
Despite the lack of a consensus on how to diagnose lipodystrophy, 
we believe that the method employed in this study was the most 
appropriate because the patient's self report and the medical 
confirmation criteria are regarded as indispensable for the diagnosis of 
a temporal relationship between perceived changes in redistribution 
of body fat in conjunction with the use of HAART. Although this is a 
subjective method, it is one of the most widely used and recommended 
methods for the diagnosis of lipodistrofia6,10,19,23 and is inexpensive. 
In the present study, the group that had been on HAART longer 
had higher rates of lipodystrophy, which strengthens the temporal 
relationship of HAART use with the development of the syndrome19, 22.
Studies by Martinez et al.24 and Lichtenstein et al.25 reported that 
lipodystrophy was associated with higher levels of CD4. These results 
coincide with the literature, as we also found a higher proportion 
of individuals with lipodystrophy who also had a CD4 greater than 
282 cells/mm3.
A statistically significant association between the level of physical 
activity (active and sedentary) and the CD4 levels was also observed, 
where more active patients had higher CD4 levels. Some studies have 
reported that increased CD4 is associated with the level of physical 
activity26,27. However, although the data seem to support these 
findings, this research presents a limitation. It is not clear whether 
the investigated subjects had higher CD4 because they were active 
or if they were more active because they had higher levels of CD4. 
Santos et al.28 found that patients, assessed by Bouchard questionnaire, 
that presented low levels of CD4+ lymphocytes, also had low physical 
domain scores, which suggests that individuals with weakened 
immune systems are more prone to physical inactivity.
The patients in the older group had lower levels of CD4. Similarly, 
Eidam et al.29 also performed research on the lifestyles of people living 
with HIV and dichotomized the variable CD4+ lymphocyte count 
and age according to the values of central tendency and variability.
The present study found an association of lipodystrophy with 
physical activity level. The active subjects had a lower incidence of 
lipodystrophy as compared to the sedentary subjects. Additionally, it 
is noteworthy that the magnitude of this difference was significant; the 
physically active patients were 79% less likely to have lipodystrophy 
than the sedentary patients.
Some studies, such as those by Mutimura et al.9, Robinson et al.10, 
Lindegaard et al.11, Terry et al.12 and Thoni et al.,13 have suggested 
that regular exercise is beneficial for people living with HIV/AIDS. 
They also reported a decrease in the excessive accumulation of trunk 
body fat and improvement in the metabolic variables related to it, 
which suggests that there is a valid alternative for the treatment of 
lipodystrophy.
Few studies14-16 were found in the literature that investigated the 
relationship of general physical activity and the body composition of 
HIV/AIDS patients, and only one of them16 addressed lipodystrophy. 
The findings from these few papers are consistent with the findings 
of this research, which indicates that there is an inverse relationship 
between physical activity and the concentration of central adiposity.
Florindo et al.14 investigated the relationship between habitual 
physical activity and body fat in HIV/AIDS patients using 
antiretroviral therapy. To do so, they assessed the physical activity 
of patients using the Baecke questionnaire and measured the 
concentration of central subcutaneous fat (by skinfolds) and the 
waist/hip ratio. The data were adjusted for sex, age, education, caloric 
intake, body mass index, smoking, time of HIV diagnosis, CD4 and the 
duration of protease inhibitor use. They observed a significant negative 
correlation between physical activity and central fat and a significant 
negative correlation between physical activity and waist/hip ratio.
Ramirez-Marrero et al.15 studied HIV/AIDS patients on 
antiretroviral therapy and observed that the active subjects, when 
compared to the sedentary subjects, showed lower total and central 
fat, which was estimated from the sum of skinfolds. Domingo et al.16 
found that 42.9% of patients without and 21.2% of patients with 
lipodystrophy were physically active. In the bivariate analysis to assess 
factors that influence lipodystrophy, the level of physical activity was 
found to be associated with lipodystrophy.
The previous studies also found a strong correlation between 
physical activity and body fat; however, only one study16 specifically 
addressed lipodystrophy. Therefore, additional studies are required 
In addition, the present study also collected more data, which further 
demonstrated the protective effect of physical activity in this context.
It is well established in the literature that the amount of body 
fat, especially fat concentrated in the central part of the body, is 
a risk factor for cardiovascular and metabolic diseases. Thus, the 
evidence from the trunk fat percentage is much higher in the group 
with lipodystrophy compared to the group without (Table 5), which 
reinforces the concern about harm that may arise from lipodystrophy6-8.
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